Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma
Masatoshi Kudo
Topics & Concepts
TremelimumabDurvalumabMedicineHepatocellular carcinomaOncologyInternal medicineCancerImmunotherapyNivolumabIpilimumabHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentHepatitis B Virus Studies